Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-31

Clinical Trial Update: To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen [Phase 3]

View source ↗

Summary

Phase 3 trial completed comparing Follitropin alfa Liquid Pen with Follitropin Beta Liquid Pen to evaluate convenience, safety and efficacy in infertility with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Follitropin alfa Liquid Pen (follitropin alfa)
  • Follitropin beta Liquid Pen (follitropin beta)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Ovulation Induction | Phase 3 | Status: COMPLETED